Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

58 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,137,514 shares of 86,307,537 outstanding shares and own 24.49% of the company stock.
Largest 10 shareholders include FMR LLC (8,196,203 shares), Casdin Capital, LLC (3,206,380 shares), FEDERATED HERMES, INC. (1,164,094 shares), RA CAPITAL MANAGEMENT, L.P. (914,094 shares), Avidity Partners Management LP (851,522 shares), BlackRock Inc. (827,423 shares), Octagon Capital Advisors LP (702,623 shares), MARSHALL WACE, LLP (701,338 shares), Logos Global Management LP (614,095 shares), and HHLR ADVISORS, LTD. (614,095 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.